Hormesis in Health and Disease: Molecular Mechanisms

Anna Meiliana, Andi Wijaya


BACKGROUND: Hormesis was initially defined as a phenomenon where a small dose of harmful agent exposure to living organisms gives beneficial effects. The dose and time of this ‘tress’ exposure has become the object of investigation across the broad range of biomedical studies.

CONTENT: Hormesis characterized by the biphasic dose-effect or time-effect relationship for any substance. Some hormetic mechanisms performed biological plasticity, involve oxidative damage which instead induce antioxidant enzyme production in various cells. Early-life stress can increase resilience in later life and lack of stress can lead to vulnerability. Many stressors like dietary factors and natural environmental toxins can be occupied for healthy growth or homeostasis, which exemplifies how illness is the doorway to health.

SUMMARY: Hormesis reconcile many paradoxical phenomena exert opposite effects of the same substance, either a xenobiotic or an endogenous substance, a hormone or a metabolite, a genetic manipulation or an epigenetic alteration, an experimental intervention or a natural event. Human bodies are highly adaptive. A resilient body would be resulted after the ‘training’. In this review, we will elucidate the hormesis’ definition, mechanisms and pathways, and also how hormesis impacts in human health and lifespan.

KEYWORDS: biphasic, cell signaling, dose response, hormesis, preconditioning

Full Text:



Gems D, Partridge L. Stress-response hormesis and aging: “That which does not kill us makes us stronger.” Cell Metab. 2008; 7: 200-3, CrossRef.

Li X, Yang T, Sun Z. Hormesis in health and chronic diseases. Trends Endocrinol Metab. 2019; 30: 944-58, CrossRef.

Omiecinski CJ, Vanden Heuvel JP, Perdew GH, Peters JM. Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci Off J Soc Toxicol. 2011; 120 (Suppl 1): S49-75, CrossRef.

Russell WL. The effect of radiation dose rate and fractionation on mutation in mice. In: Sobels FH, editor. Repair from Genetic Radiation Damage and Differential Radiosensitivity in Germ Cells. Proceedings of an International Symposium. Leiden: University of Leiden; 1963. p. 205-17.

Russell WL. Environmental effects of producing electric power, Joint Committee on Atomic Energy, 91st Congress of the United States, Washington, DC, USA, October and November 1969. In: Summary of the Effect of Dose Rate on the Induction of Mutations by Radiation in the Mouse. Washington, DC: USA Government Printing Office; 1969. p.1108.

Russell WL, Russell LB, Kelly EM. Radiation dose rate and mutation frequency. Science. 1958; 128: 1546-50, CrossRef.

Calabrese EJ. Hormesis and medicine. Br J Clin Pharmacol. 2008; 66: 594-617, CrossRef.

Calabrese EJ. Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson Law are manifestations of hormesis. Ageing Res Rev. 2008; 7: 8-20, CrossRef.

Southam C, Ehrlich J. Effects of extracts of western red-cedar heartwood on certain wood-decaying fungi in culture. Phytopathology. 1943; 33: 517-24, article.

Calabrese EJ, Baldwin LA. Defining hormesis. Hum Exp Toxicol. 2002; 21: 91-7, CrossRef.

Cypser JR, Johnson TE. Multiple stressors in Caenorhabditis elegans induce stress hormesis and extended longevity. J Gerontol Ser A. 2002; 57: B109-14, CrossRef.

Luckey TD. Hormesis with Ionizing Radiation. Boca Raton: CRC Press; 2019, CrossRef.

Luckey TD. Radiation Hormesis. Boca Raton: CRC Press; 1991, CrossRef.

Calabrese EJ, Baldwin LA. Hormesis: a generalizable and unifying hypothesis. Crit Rev Toxicol. 2001; 31: 353-424, CrossRef.

Pickrell JA, Oehme FW. Invited response to definition of hormesis. Hum Exp Toxicol. 2002; 21: 107-9, CrossRef.

Feynman RP, Robbins JW. The Pleasure of Finding Things Out: the Best Short Works of Richard P. Feynman. New York: Basic Books; 2005.

Calabrese EJ. Hormesis: why it is important to toxicology and toxicologists. Environ Toxicol Chem. 2008; 27: 1451-74, CrossRef.

Mattson MP. Hormesis defined. Ageing Res Rev. 2008; 7: 1-7, CrossRef.

Calabrese EJ. Hormetic mechanisms. Crit Rev Toxicol. 2013; 43: 580-606, CrossRef.

Calabrese EJ, Mattson MP. How does hormesis impact biology, toxicology, and medicine? Npj Aging Mech Dis. 2017; 3: 13, CrossRef.

Szabadi E. A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol. 1977; 69: 101-12, CrossRef.

Accomazzo MR, Cattaneo S, Nicosia S, Rovati GE. Bell-shaped curves for prostaglandin-induced modulation of adenylate cyclase: two mutually opposing effects. Eur J Pharmacol. 2002; 454: 107-14, CrossRef.

Alfonzo MJ, de Becemberg IL, de Villaroel SS, de Herrera VN, Misle AJ, de Alfonzo RG. Two opposite signal transducing mechanisms regulate a G-protein-coupled guanylyl cyclase. Arch Biochem Biophys. 1998; 350: 19-25, CrossRef.

Järv J. A model of non-exclusive binding of agonist and antagonist on G-protein coupled receptors. J Theor Biol. 1995; 175: 577-82, CrossRef.

Järv J, Hautala R, Åkerman KEO. Dual effect of muscarinic receptor agonists on Ca2+ mobilization in SH-SY5Y neuroblastoma cells. Eur J Pharmacol Mol Pharmacol. 1995; 291: 43-50, CrossRef.

Wikimedia Commons [Internet]. File: Signal transduction pathways.svg [cited Mar 23, 2020]. Available from: https://commons.wikimedia.org/.

Sharma GD, He J, Bazan HEP. p38 and ERK1/2 Coordinate cellular migration and proliferation in epithelial wound healing evidence of cross-talk activation between MAP kinase cascades. J Biol Chem. 2003; 278: 21989-97, CrossRef.

Cheung LWT, Leung PCK, Wong AST. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. Cancer Res. 2006; 66: 10902-10, CrossRef.

Bianchi R, Kastrisianaki E, Giambanco I, Donato R. S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem. 2011; 286: 7214-26, CrossRef.

Simons AM, Wagner I. The characterization of complex continuous norms of reaction. Oikos. 2007; 116: 986-94, CrossRef.

Huey RB, Kingsolver JG. Evolution of thermal sensitivity of ectotherm performance. Trends Ecol Evol. 1989; 4: 131-5, CrossRef.

Izem R, Kingsolver JG. Variation in continuous reaction norms: quantifying directions of biological interest. Am Nat. 2005; 166: 277-89, CrossRef.

de Jong G. Phenotypic plasticity as a product of selection in a variable environment. Am Nat. 1995; 145: 493-512, CrossRef.

Calabrese EJ, Mattson MP. Hormesis provides a generalized quantitative estimate of biological plasticity. J Cell Commun Signal. 2011; 5: 25-38, CrossRef.

Puzzo D, Privitera L, Palmeri A. Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory. Neurobiol Aging. 2012; 33: 1484.e15-1484.e24, CrossRef.

Via S, Gomulkiewicz R, De Jong G, Scheiner SM, Schlichting CD, Van Tienderen PH. Adaptive phenotypic plasticity: consensus and controversy. Trends Ecol Evol. 1995; 10: 212-7, CrossRef.

Costantini D. Hormesis promotes evolutionary change. Dose-Response. 2019; 17: 1559325819843376, CrossRef.

Calabrese EJ, Bachmann KA, Bailer AJ, Bolger PM, Borak J, Cai L, et al. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol. 2007; 222: 122-8, CrossRef.

Calabrese EJ, Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol. 2005; 202: 289-301, CrossRef.

Calabrese EJ, Blain RB. Hormesis and plant biology. Environ Pollut Barking Essex 1987. 2009; 157: 42-8, CrossRef.

Calabrese EJ. Hormesis: Path and progression to significance. Int J Mol Sci. 2018; 19: 2871, CrossRef.

Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003; 285: H579-88, CrossRef.

Hausenloy DJ. Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic science). Curr Pharm Des. 2013; 19: 4544-63, CrossRef.

Hausenloy DJ, Yellon DM. The therapeutic potential of ischemic conditioning: an update. Nat Rev Cardiol. 2011; 8: 619-29, CrossRef.

Ito T, Sawauchi K. Inhibitory effects on cadmium-induced testicular damage by pretreatment with smaller cadmium dose. Okajimas Folia Anat Jpn. 1966; 42: 107-17, CrossRef.

Calabrese EJ. Preconditioning is hormesis part I: Documentation, dose-response features and mechanistic foundations. Pharmacol Res. 2016; 110: 242-64, CrossRef.

Allende-Vigo MZ. Pathophysiologic mechanisms linking adipose tissue and cardiometabolic risk. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. 2010; 16: 692-8, CrossRef.

Kopelman PG. Obesity as a medical problem. Nature. 2000; 404: 635-43, CrossRef.

Thakur ML, Sharma S, Kumar A, Bhatt SP, Luthra K, Guleria R, et al. Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis. 2012; 223: 507-11, CrossRef.

Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatol Baltim Md. 2005; 42: 473-80, CrossRef.

Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, Alves MJNN, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PloS One. 2010; 5: e12065, CrossRef.

Trzepizur W, Gaceb A, Arnaud C, Ribuot C, Levy P, Martinez MC, et al. Vascular and hepatic impact of short-term intermittent hypoxia in a mouse model of metabolic syndrome. PLOS ONE. 2015; 10: e0124637, CrossRef.

Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet Lond Engl. 2005; 365: 1046-53, CrossRef.

Minville C, Hilleret MN, Tamisier R, Aron-Wisnewsky J, Clement K, Trocme C, et al. Nonalcoholic fatty liver disease, nocturnal hypoxia, and endothelial function in patients with sleep apnea. Chest. 2014; 145: 525-33, CrossRef.

Priou P, Le Vaillant M, Meslier N, Chollet S, Masson P, Humeau MP, et al. Independent association between obstructive sleep apnea severity and glycated hemoglobin in adults without diabetes. Diabetes Care. 2012; 35: 1902-6, CrossRef.

Trzepizur W, Le Vaillant M, Meslier N, Pigeanne T, Masson P, Humeau MP, et al. Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest. 2013; 143: 1584-9, CrossRef.

Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O’Connor GT, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009; 6: e1000132, CrossRef.

Manukhina EB, Jasti D, Vanin AF, Downey HF. Intermittent hypoxia conditioning prevents endothelial dysfunction and improves nitric oxide storage in spontaneously hypertensive rats. Exp Biol Med Maywood NJ. 2011; 236: 867-73, CrossRef.

Milano G, Abruzzo PM, Bolotta A, Marini M, Terraneo L, Ravara B, et al. Impact of the phosphatidylinositide 3-kinase signaling pathway on the cardioprotection induced by intermittent hypoxia. PLoS ONE. 2013; 8: e76659, CrossRef.

Almendros I, Wang Y, Gozal D. The polymorphic and contradictory aspects of intermittent hypoxia. Am J Physiol Lung Cell Mol Physiol. 2014; 307: L129-40, CrossRef.

Manukhina EB, Downey HF, Mallet RT. Role of nitric oxide in cardiovascular adaptation to intermittent hypoxia. Exp Biol Med. 2006; 231: 343-65, CrossRef.

Meerson FZ, Pshennikova MG, Malyshev IY. Adaptive defense of the organism. Ann NY Acad Sci. 1996; 793: 371-85, CrossRef.

Serebrovskaya TV. Intermittent hypoxia research in the former soviet union and the commonwealth of independent States: history and review of the concept and selected applications. High Alt Med Biol. 2002; 3: 205-21, CrossRef.

Calabrese EJ. Preconditioning is hormesis part II: How the conditioning dose mediates protection: Dose optimization within temporal and mechanistic frameworks. Pharmacol Res. 2016; 110: 265-75, CrossRef.

Dezfulian C, Garrett M, Gonzalez NR. Clinical application of preconditioning and postconditioning to achieve neuroprotection. Transl Stroke Res. 2013; 4: 19-24, CrossRef.

Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74: 1124-36, CrossRef.

Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al. “Ischemic tolerance” phenomenon found in the brain. Brain Res. 1990; 528: 21-4, CrossRef.

Gidday JM. Extending injury- and disease-resistant CNS phenotypes by repetitive epigenetic conditioning. Front Neurol. 2015; 6: 42, CrossRef.

Kishimoto S, Uno M, Okabe E, Nono M, Nishida E. Environmental stresses induce transgenerationally inheritable survival advantages via germline-to-soma communication in Caenorhabditis elegans. Nat Commun. 2017; 8: 14031, CrossRef.

Ristow M, Schmeisser K. Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response. 2014; 12: 288-341, CrossRef.

Lithgow GJ, White TM, Melov S, Johnson TE. Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc Natl Acad Sci USA. 1995; 92: 7540-4, CrossRef.

Wu D, Rea SL, Yashin AI, Johnson TE. Visualizing hidden heterogeneity in isogenic populations of C. elegans. Exp Gerontol. 2006; 41: 261-70, CrossRef.

Schulz TJ, Zarse K, Voigt A, Urban N, Birringer M, Ristow M. Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell Metab. 2007; 6: 280-93, CrossRef.

Masoro EJ. Hormesis and the antiaging action of dietary restriction. Exp Gerontol. 1998; 33: 61-6, CrossRef.

Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11: 298-300, CrossRef.

D’Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007; 8: 813-24, CrossRef.

Van Raamsdonk JM, Hekimi S. Superoxide dismutase is dispensable for normal animal lifespan. Proc Natl Acad Sci USA. 2012; 109: 5785-90, CrossRef.

Shibata Y, Branicky R, Landaverde IO, Hekimi S. Redox regulation of germline and vulval development in Caenorhabditis elegans. Science. 2003; 302: 1779-82, CrossRef.

Van Raamsdonk JM, Hekimi S. Deletion of the mitochondrial superoxide dismutase sod-2 extends lifespan in Caenorhabditis elegans. PLoS Genet. 2009; 5: e1000361, CrossRef.

Yang W, Hekimi S. A mitochondrial superoxide signal triggers increased longevity in Caenorhabditis elegans. PLoS Biol. 2010; 8: e1000556, CrossRef.

Zarse K, Schmeisser S, Groth M, Priebe S, Beuster G, Kuhlow D, et al. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 2012; 15: 451-65, CrossRef.

Lee SJ, Hwang AB, Kenyon C. Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr Biol CB. 2010; 20: 2131-6, CrossRef.

Yang W, Li J, Hekimi S. A measurable increase in oxidative damage due to reduction in superoxide detoxification fails to shorten the life span of long-lived mitochondrial mutants of Caenorhabditis elegans. Genetics. 2007; 177: 2063-74, CrossRef.

Baker BM, Nargund AM, Sun T, Haynes CM. Protective coupling of mitochondrial function and protein synthesis via the eIF2α kinase GCN-2. PLoS Genet. 2012; 8(6): e1002760, CrossRef.

Braeckman BP, Houthoofd K, Brys K, Lenaerts I, De Vreese A, Van Eygen S, et al. No reduction of energy metabolism in Clk mutants. Mech Ageing Dev. 2002; 123: 1447-56, CrossRef.

Kayser EB, Sedensky MM, Morgan PG. The effects of complex I function and oxidative damage on lifespan and anesthetic sensitivity in Caenorhabditis elegans. Mech Ageing Dev. 2004; 125: 455-64, CrossRef.

Yang YY, Gangoiti JA, Sedensky MM, Morgan PG. The effect of different ubiquinones on lifespan in Caenorhabditis elegans. Mech Ageing Dev. 2009; 130: 370-6, CrossRef.

Labuschagne CF, Stigter ECA, Hendriks MMWB, Berger R, Rokach J, Korswagen HC, et al. Quantification of in vivo oxidative damage in Caenorhabditis elegans during aging by endogenous F3-isoprostane measurement. Aging Cell. 2013; 12: 214-23, CrossRef.

Petriv OI, Rachubinski RA. Lack of peroxisomal catalase causes a progeric phenotype in Caenorhabditis elegans. J Biol Chem. 2004; 279: 19996-20001, CrossRef.

Van Raamsdonk JM, Meng Y, Camp D, Yang W, Jia X, Bénard C, et al. Decreased energy metabolism extends life span in Caenorhabditis elegans without reducing oxidative damage. Genetics. 2010; 185: 559-71, CrossRef.

Honda Y, Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J Off Publ Fed Am Soc Exp Biol. 1999; 13: 1385-93, CrossRef.

Cristina D, Cary M, Lunceford A, Clarke C, Kenyon C. A regulated response to impaired respiration slows behavioral rates and increases lifespan in Caenorhabditis elegans. PLoS Genet. 2009; 5: e1000450, CrossRef.

Schaar CE, Dues DJ, Spielbauer KK, Machiela E, Cooper JF, Senchuk M, et al. Mitochondrial and cytoplasmic ROS have opposing effects on lifespan. PLOS Genet. 2015; 11: e1004972, CrossRef.

Wiederkehr A, Wollheim CB. Minireview: implication of mitochondria in insulin secretion and action. Endocrinology. 2006; 147: 2643-9, CrossRef.

Ristow M. Oxidative metabolism in cancer growth. Curr Opin Clin Nutr Metab Care. 2006; 9: 339-45, CrossRef.

Fukui H, Moraes CT. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? Trends Neurosci. 2008; 31: 251-6, CrossRef.

Tatsuta T, Langer T. Quality control of mitochondria: protection against neurodegeneration and ageing. EMBO J. 2008; 27: 306-14, CrossRef.

Bratic A, Larsson NG. The role of mitochondria in aging. J Clin Invest. 2013; 123: 951-7, CrossRef.

Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature. 2004; 429: 417-23, CrossRef.

Rattan SIS. Hormesis in aging. Ageing Res Rev. 2008; 7: 63-78, CrossRef.

Lamming DW, Wood JG, Sinclair DA. Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol. 2004; 53: 1003-9, CrossRef.

Yanase S, Hartman PS, Ito A, Ishii N. Oxidative stress pretreatment increases the X-radiation resistance of the nematode Caenorhabditis elegans. Mutat Res. 1999; 426: 31-9, CrossRef.

Tapia PC. Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients: “Mitohormesis” for health and vitality. Med Hypotheses. 2006; 66: 832-43, CrossRef.

Fontana L, Klein S. Aging, adiposity, and calorie restriction. JAMA. 2007; 297: 986-94, CrossRef.

Takemori K, Kimura T, Shirasaka N, Inoue T, Masuno K, Ito H. Food restriction improves glucose and lipid metabolism through Sirt1 expression: a study using a new rat model with obesity and severe hypertension. Life Sci. 2011; 88: 1088-94, CrossRef.

He X, Zhao X, Gu Q, Shen J, Hu Y, Hu R. Calorie restriction from a young age preserves the functions of pancreatic β cells in aging rats. Tohoku J Exp Med. 2012; 227: 245-52, CrossRef.

Harvey AE, Lashinger LM, Otto G, Nunez NP, Hursting SD. Decreased systemic IGF-1 in response to calorie restriction modulates murine tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression. Mol Carcinog. 2013; 52: 997-1006, CrossRef.

Willette AA, Bendlin BB, Colman RJ, Kastman EK, Field AS, Alexander AL, et al. Calorie restriction reduces the influence of glucoregulatory dysfunction on regional brain volume in aged rhesus monkeys. Diabetes. 2012; 61: 1036-42, CrossRef.

Ryan AS, Ortmeyer HK, Sorkin JD. Exercise with calorie restriction improves insulin sensitivity and glycogen synthase activity in obese postmenopausal women with impaired glucose tolerance. Am J Physiol Endocrinol Metab. 2012; 302: E145-52, CrossRef.

Larson-Meyer DE, Heilbronn LK, Redman LM, Newcomer BR, Frisard MI, Anton S, et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care. 2006; 29: 1337-44, CrossRef.

Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. 2006; 295: 1539-48, CrossRef.

Lefevre M, Redman LM, Heilbronn LK, Smith JV, Martin CK, Rood JC, et al. Caloric restriction alone and with exercise improves CVD risk in healthy non-obese individuals. Atherosclerosis. 2009; 203: 206-13, CrossRef.

Koizumi A, Weindruch R, Walford RL. Influences of dietary restriction and age on liver enzyme activities and lipid peroxidation in mice. J Nutr. 1987; 117: 361-7, CrossRef.

Semsei I, Rao G, Richardson A. Changes in the expression of superoxide dismutase and catalase as a function of age and dietary restriction. Biochem Biophys Res Commun. 1989; 164: 620-5, CrossRef.

Rao G, Xia E, Nadakavukaren MJ, Richardson A. Effect of dietary restriction on the age-dependent changes in the expression of antioxidant enzymes in rat liver. J Nutr. 1990; 120: 602-9, CrossRef.

Pieri C, Falasca M, Marcheselli F, Moroni F, Recchioni R, Marmocchi F, et al. Food restriction in female Wistar rats: V. Lipid peroxidation and antioxidant enzymes in the liver. Arch Gerontol Geriatr. 1992; 14: 93-9, CrossRef.

Youngman LD, Park JY, Ames BN. Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. Proc Natl Acad Sci USA. 1992; 89: 9112-6, CrossRef.

Xia E, Rao G, Van Remmen H, Heydari AR, Richardson A. Activities of antioxidant enzymes in various tissues of male Fischer 344 rats are altered by food restriction. J Nutr. 1995; 125: 195-201, CrossRef.

Barros MH, Bandy B, Tahara EB, Kowaltowski AJ. Higher respiratory activity decreases mitochondrial reactive oxygen release and increases life span in Saccharomyces cerevisiae. J Biol Chem. 2004; 279: 49883-8, CrossRef.

Mahlke MA, Cortez LA, Ortiz MA, Rodriguez M, Uchida K, Shigenaga MK, et al. The anti-tumor effects of calorie restriction are correlated with reduced oxidative stress in ENU-induced gliomas. Pathobiol Aging Age Relat Dis. 2011; 1: 10.3402/pba.v1i0.7189, CrossRef.

Qiu X, Brown K, Hirschey MD, Verdin E, Chen D. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010; 12: 662-7, CrossRef.

Rippe C, Lesniewski L, Connell M, LaRocca T, Donato A, Seals D. Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell. 2010; 9: 304-12, CrossRef.

Sreekumar R, Unnikrishnan J, Fu A, Nygren J, Short KR, Schimke J, et al. Effects of caloric restriction on mitochondrial function and gene transcripts in rat muscle. Am J Physiol Endocrinol Metab. 2002; 283: E38-43, CrossRef.

Park S, Park NY, Valacchi G, Lim Y. Calorie restriction with a high-fat diet effectively attenuated inflammatory response and oxidative stress-related markers in obese tissues of the high diet fed rats. Mediators Inflamm. 2012; 2012: 984643, CrossRef.

Schmeisser S, Priebe S, Groth M, Monajembashi S, Hemmerich P, Guthke R, et al. Neuronal ROS signaling rather than AMPK/sirtuin-mediated energy sensing links dietary restriction to lifespan extension. Mol Metab. 2013; 2: 92-102, CrossRef.

Beaudart C, McCloskey E, Bruyère O, Cesari M, Rolland Y, Rizzoli R, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016; 16: 170, CrossRef.

Fierro-González JC, González-Barrios M, Miranda-Vizuete A, Swoboda P. The thioredoxin TRX-1 regulates adult lifespan extension induced by dietary restriction in Caenorhabditis elegans. Biochem Biophys Res Commun. 2011; 406: 478-82, CrossRef.

Lillig CH, Holmgren A. Thioredoxin and related molecules--from biology to health and disease. Antioxid Redox Signal. 2007; 9: 25-47, CrossRef.

Berndt C, Lillig CH, Holmgren A. Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim Biophys Acta. 2008; 1783: 641-50, CrossRef.

Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med. 2004; 36: 1208-13. , CrossRef.

Papaiahgari S, Zhang Q, Kleeberger SR, Cho HY, Reddy SP. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid Redox Signal. 2006; 8: 43-52, CrossRef.

Kim YC, Masutani H, Yamaguchi Y, Itoh K, Yamamoto M, Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem. 2001; 276: 18399-406, CrossRef.

Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991; 266: 11632-9, PMID.

Kops GJPL, Dansen TB, Polderman PE, Saarloos I, Wirtz KWA, Coffer PJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002; 419: 316-21, CrossRef.

Nemoto S, Finkel T. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science. 2002; 295: 2450-2, CrossRef.

Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004; 303: 2011-5, CrossRef.

Friedman JR, Kaestner KH. The Foxa family of transcription factors in development and metabolism. Cell Mol Life Sci CMLS. 2006; 63: 2317-28, CrossRef.

Panowski SH, Wolff S, Aguilaniu H, Durieux J, Dillin A. PHA-4/Foxa mediates diet-restriction-induced longevity of C. elegans. Nature. 2007; 447: 550-5, CrossRef.

Barger JL, Walford RL, Weindruch R. The retardation of aging by caloric restriction: its significance in the transgenic era. Exp Gerontol. 2003; 38: 1343-51, CrossRef.

Smith JV, Heilbronn LK, Ravussin E. Energy restriction and aging. Curr Opin Clin Nutr Metab Care. 2004; 7: 615-22, CrossRef.

Martin B, Mattson MP, Maudsley S. Caloric restriction and intermittent fasting: two potential diets for successful brain aging. Ageing Res Rev. 2006; 5: 332-53, CrossRef.

Grundy SM. The optimal ratio of fat-to-carbohydrate in the diet. Annu Rev Nutr. 1999; 19: 325-41, CrossRef.

Wijendran V, Hayes KC. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr. 2004; 24: 597-615, CrossRef.

Schulze MB, Hu FB. Primary prevention of diabetes: what can be done and how much can be prevented? Annu Rev Public Health. 2005; 26: 445-67, CrossRef.

Heber D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J Postgrad Med. 2004; 50: 145-9, PMID.

Carpentier YA, Portois L, Malaisse WJ. n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr. 2006; 83 (6 Suppl): 1499S-504S, CrossRef.

Hu FB, Stampfer MJ. Nut consumption and risk of coronary heart disease: a review of epidemiologic evidence. Curr Atheroscler Rep. 1999; 1: 204-9, CrossRef.

Simopoulos AP. The Mediterranean diets: What is so special about the diet of Greece? The scientific evidence. J Nutr. 2001; 131: 3065S-73S, CrossRef.

Mattson MP. Dietary factors, hormesis and health. Ageing Res Rev. 2008; 7: 43-8, CrossRef.

Johnson JB, Summer W, Cutler RG, Martin B, Hyun D-H, Dixit VD, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007; 42: 665-74, CrossRef.

Heydari AR, Wu B, Takahashi R, Strong R, Richardson A. Expression of heat shock protein 70 is altered by age and diet at the level of transcription. Mol Cell Biol. 1993; 13: 2909-18, CrossRef.

Guo Z, Ersoz A, Butterfield DA, Mattson MP. Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. J Neurochem. 2000; 75: 314-20, CrossRef.

Ugochukwu NH, Figgers CL. Dietary caloric restriction improves the redox status at the onset of diabetes in hepatocytes of streptozotocin-induced diabetic rats. Chem Biol Interact. 2007; 165: 45-53, CrossRef.

Hyun DH, Emerson SS, Jo DG, Mattson MP, de Cabo R. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci USA. 2006; 103: 19908-12, CrossRef.

Sanz A, Pamplona R, Barja G. Is the mitochondrial free radical theory of aging intact? Antioxid Redox Signal. 2006; 8: 582-99, CrossRef.

Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005; 434: 113-8, CrossRef.

Trewavas A, Stewart D. Paradoxical effects of chemicals in the diet on health. Curr Opin Plant Biol. 2003; 6: 185-90, CrossRef.

Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006; 5: 493-506, CrossRef.

Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA. 2002; 99: 11908-13, CrossRef.

Balogun E, Hoque M, Gong P, Killeen E, Green CJ, Foresti R, et al. Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J. 2003; 371: 887-95, CrossRef.

Chen C, Pung D, Leong V, Hebbar V, Shen G, Nair S, et al. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radic Biol Med. 2004; 37: 1578-90, CrossRef.

Frescas D, Valenti L, Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J Biol Chem. 2005; 280: 20589-95, CrossRef.

Mabuchi T, Kitagawa K, Kuwabara K, Takasawa K, Ohtsuki T, Xia Z, et al. Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J Neurosci Off J Soc Neurosci. 2001; 21: 9204-13, CrossRef.

Mattson MP, Meffert MK. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006; 13: 852-60, CrossRef.

World Health Organization. Global Status Report on Alcohol and Health 2018. Geneva: WHO; 2018, article.

Centers for Disease Control and Prevention (CDC) [Internet]. Alcohol and Public Health: Alcohol-Related Disease Impact (ARDI) [cited 2020 May 13]. Available from: https://nccd.cdc.gov/.

Stahre M, Roeber J, Kanny D, Brewer RD, Zhang X. Contribution of excessive alcohol consumption to deaths and years of potential life lost in the United States. Prev Chronic Dis. 2014; 11: E109, CrossRef.

Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD. 2010 National and state costs of excessive alcohol consumption. Am J Prev Med. 2015; 49: e73-9, CrossRef.

Fernández-Solà J. Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol. 2015; 12: 576-87, CrossRef.

Mukamal KJ, Rimm EB. Alcohol consumption: risks and benefits. Curr Atheroscler Rep. 2008; 10: 536-43, CrossRef.

Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988; 319: 267-73, CrossRef.

Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addict Abingdon Engl. 2012; 107: 1246-60, CrossRef.

Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014; 12: 182, CrossRef.

Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011; 342: d671, CrossRef.

O’Keefe JH, Bybee KA, Lavie CJ. Alcohol and cardiovascular health: the razor-sharp double-edged sword. J Am Coll Cardiol. 2007; 50: 1009-14, CrossRef.

Krenz M, Korthuis RJ. Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol. 2012; 52: 93-104, CrossRef.

Perissinotto E, Buja A, Maggi S, Enzi G, Manzato E, Scafato E, et al. Alcohol consumption and cardiovascular risk factors in older lifelong wine drinkers: The Italian Longitudinal Study on Aging. Nutr Metab Cardiovasc Dis. 2010; 20: 647-55, CrossRef.

Wakabayashi I. Associations between alcohol drinking and multiple risk factors for atherosclerosis in smokers and nonsmokers. Angiology. 2010; 61: 495-503, CrossRef.

DOI: https://doi.org/10.18585/inabj.v12i4.1315

Copyright (c) 2020 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute